Indianapolis, IN, United States of America

Jason Scott Sawyer

USPTO Granted Patents = 72 

 

 

Average Co-Inventor Count = 5.6

ph-index = 12

Forward Citations = 450(Granted Patents)


Inventors with similar research interests:


Company Filing History:


Years Active: 1996-2017

Loading Chart...
Loading Chart...
Loading Chart...
72 patents (USPTO):Explore Patents

Title: **Jason Scott Sawyer: Innovator and Contributor to Pharmaceutical Advancements**

Introduction

Jason Scott Sawyer is a prolific inventor based in Indianapolis, IN, holding an impressive total of 72 patents to his name. His innovative contributions primarily focus on creating compounds for treating various types of cancer and other medical conditions.

Latest Patents

Among Jason's latest patents is his work on aminopyridyloxypyrazole compounds. This invention relates to novel compounds that inhibit the activity of transforming growth factor beta receptor 1 (TGFβR1). These compounds are formulated into pharmaceutical compositions and are intended for use in treating a range of cancers, including colon cancer, melanoma, hepatocellular carcinoma, renal cancer, glioblastoma, pancreatic cancer, myelodysplastic syndrome, lung cancer, and gastric cancer, as well as fibrosis, particularly liver fibrosis and chronic kidney disease.

Another significant invention by Jason is centered on AKT inhibitors. This patent provides inhibitors of the formula designated as Formula I, along with pharmaceutical compositions that comprise these compounds. He also highlights methods of using these compounds in medical applications.

Career Highlights

Jason has made notable strides in the pharmaceutical industry, working with prominent companies such as Eli Lilly and Company and Lilly Icos LLC. His innovative spirit and dedication to advancing medical treatments have led to his substantial patent portfolio.

Collaborations

Throughout his career, Jason Scott Sawyer has collaborated with esteemed colleagues, such as Douglas Wade Beight and Robert T Shuman. These partnerships have contributed greatly to his ongoing research and the successful development of his inventions.

Conclusion

Jason Scott Sawyer exemplifies the spirit of innovation within the pharmaceutical realm. His commitment to developing treatments for cancer and other serious health conditions is evident through his extensive patent portfolio and collaborative efforts. As he continues to advance his research, the impact of his work will undoubtedly benefit many in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…